ArticleChinese medicine2025
The immunomodulatory effects of sodium new houttuyfonate on different states of macrophage against Aspergillus fumigatus infection via distinct mechanism in invasive pulmonary aspergillosis.
Article in Chinese medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Rethinking the immune recognition of cell walls in human fungal pathogens: Mechanisms, controversies and translational significance.Virulence · 2026Review
- The Immunomodulatory Effects of Mannan on the Fungicidal Activity of Macrophages AgainstMicroorganisms · 2026Article
- Therapeutic Effects and Mechanisms of Sodium New Houttuyfonate in a Murine Model of Intra-AbdominalInternational journal of molecular sciences · 2026Article
- Sodium new houttuyfonate inhibits the growth ofFrontiers in cellular and infection microbiology · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundInvasive pulmonary aspergillosis (IPA) is usually caused by Aspergillus fumigatus infection and associated with high morbidity and mortality in immunocompromised patients. Sodium new houttuyfonate (SNH) has antifungal and immunomodulatory properties, but the therapeutic effect against IPA remains unknown.
methodsThe therapeutic effect of SNH in mice with IPA was determined by histopathological analysis and measurements of fungal loads. The toxicity of SNH to mouse alveolar macrophages (MH-S cells) and the changes in phagocytosis ability of MH-S cells to A. fumigatus were determined by cell counting kit-8 (CCK8), microscopic observation, respectively. The biological mechanism of SNH regulating the functional changes of MH-S cells was determined by transcriptomics, real-time quantitative polymerase chain reaction (RT-qPCR), western blot, molecular docking, microRNA sequencing, and miRNA_mRNA interaction analyses.
resultsIntraperitoneal injection of SNH had a therapeutic effect in mice with IPA, and 8 μg/mL of SNH was significantly enhanced the ability of MH-S cells to phagocytize and kill A. fumigatus conidia. Moreover, SNH increased antifungal activity of MH-S cells to A. fumigatus via the TLR2/TRAF6/IRF5 and TLR2/TRAF6/ERK axes, respectively. What's more, SNH inhibited the expression of miR-328-5p and miR-6975-3p in MH-S cells, which negatively regulated TLR2 expression and the phagocytosis and killing functions of MH-S cells.
conclusionsTaken together, these findings clarify the potential immunomodulatory mechanism of SNH for treatment of IPA, suggesting that SNH is effective against A. fumigatus infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.